Epigenetic drug screen on resistant CLL cells reveals Aurora kinase inhibitors as enhancers of CD20 expression and sensitizers to treatment with CD20 monoclonal antibodies

• Authors: KOZLOVÁ Veronika; LEDEREROVÁ Aneta; DOUBEK Michael; MAYER Jiří; POSPÍŠILOVÁ Šárka; ŠMÍDA Michal
• Year of publication: 2018
• Type: Conference abstract
• MU Faculty or unit: Central European Institute of Technology
• Description: Epigenetic drug screen on resistant CLL cells reveals Aurora kinase inhibitors as enhancers of CD20 expression and sensitizers to treatment with CD20 monoclonal antibodies, Epigenetic drug screen on resistant CLL cells reveals Aurora kinase inhibitors as enhancers of CD20 expression and sensitizers to treatment with CD20 monoclonal antibodies.

Related projects

• Rezistence na léčbu monoklonálními protilátkami u B-CLL a B-lymfomů: příčiny vzniku a potenciální intervenční strategie
• CEITEC 2020
• Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit V